BEAMSTART Logo

Oncology Research International Ltd

Investigate, develop new, effective & low cost plant-derived immune-oncology therapies for treatment of cancer

About Oncology Research International Ltd

ORIL is a public-unlisted biotech start-up headquartered in Adelaide, Australia;
Founded by a cancer survivor, it has been carrying on the research work in low-cost & effective treatment of cancer based on chemical compounds found in natural recurring substance, using traditional Chinese medicine (TCM) approach;
Currently the Company’s new chemical entity ORIL19 has been approved strong efficacy in curing liver & breasts cancer during pre-clinical research; the Company has been strongly encouraged & approved by US FDA to conduct clinical phase 1 research, but is in need of approx. AU$2-5m (US$1.5m) for funding the regulatory filing costs & ongoing research expenses


People & Team

Philip Marshall

CEO of ORIL

Over 30 years experience in senior executive roles in pharma & biotech companies; Founder & Director of global specialist consultancy firm to pharma; Authorised Australia Govt. GMP Auditor; Co-investor of ORIL’s chemistry patents


Articles, Links, and Press

No articles or coverage yet.

Have a news story to share? Tell us about it.

BEAMSTART is a Global Community and News Portal for Entrepreneurship. We cover the latest news and bring together a global network of CEOs/founders, Investors, Business Leaders, and Professionals.

 

Download the Community App

Connect with the BEAMSTART Entrepreneurship Community from the palm of your hands. Connect with CEOs/Founders, Investors, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities:

PlayStore ButtonAppStore Button

© 2016 - 2021 BEAMSTART. All Rights Reserved (Legal).